2019
DOI: 10.1371/journal.pone.0217199
|View full text |Cite
|
Sign up to set email alerts
|

Predicting aquatic development and mortality rates of Aedes aegypti

Abstract: Mosquito-borne pathogens continue to be a significant burden within human populations, with Aedes aegypti continuing to spread dengue, chikungunya, and Zika virus throughout the world. Using data from a previously conducted study, a linear regression model was constructed to predict the aquatic development rates based on the average temperature, temperature fluctuation range, and larval density. Additional experiments were conducted with different parameters of average temperature and la… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
3
1

Relationship

3
1

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 40 publications
0
2
0
Order By: Relevance
“…Studies across the literature have used different validation strategies such as random sampling [ 20 , 65 - 67 ], time-based splitting [ 4 , 5 , 67 - 69 ], patient-specific splitting [ 6 , 32 , 53 , 70 , 71 ], or a combination of these methods to estimate predictive model performance. Simple random sampling–based cross-validation [ 72 , 73 ] may not fully address the generalizability aspect of the model to new patients and new time periods. Some studies [ 6 ] using a patient-based validation strategy used a part of their test data for tuning model parameters, which affected the validity of the performance estimation.…”
Section: Discussionmentioning
confidence: 99%
“…Studies across the literature have used different validation strategies such as random sampling [ 20 , 65 - 67 ], time-based splitting [ 4 , 5 , 67 - 69 ], patient-specific splitting [ 6 , 32 , 53 , 70 , 71 ], or a combination of these methods to estimate predictive model performance. Simple random sampling–based cross-validation [ 72 , 73 ] may not fully address the generalizability aspect of the model to new patients and new time periods. Some studies [ 6 ] using a patient-based validation strategy used a part of their test data for tuning model parameters, which affected the validity of the performance estimation.…”
Section: Discussionmentioning
confidence: 99%
“…The availability of big data in the healthcare sector has made machine learning (ML) a viable instrument for disease prediction [15–18]. In contrast to traditional diagnostic techniques employing population based statistics, ML methods develop models that are trained using large amounts of data.…”
Section: Introductionmentioning
confidence: 99%